Shares of Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) traded up 200% on Thursday . The stock traded as high as $45.50 and last traded at $45.50. 5,400 shares traded hands during trading, an increase of 67% from the average session volume of 3,240 shares. The stock had previously closed at $15.17.
Shionogi & Co., Ltd. Price Performance
The firm has a 50 day moving average of $39.31 and a two-hundred day moving average of $43.06.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Featured Stories
- Five stocks we like better than Shionogi & Co., Ltd.
- What is a buyback in stocks? A comprehensive guide for investors
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- Using the MarketBeat Dividend Yield Calculator
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- What Does Downgrade Mean in Investing?
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
